Back

Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: long-term results and clinical outcomes.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Catheter ablation Catheter ablation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Davide Castagno

University of Turin, Turin (Italy)

20 More presentations in this session

Presentation thumbnail
Asymptomatic cerebral embolism in ablation with the second generation PVAC Gold
Doctor F. Kece (Leuven, BE)
Abstract
Presentation thumbnail
Utilization and safety profile of catheter ablation for non-ischemic ventricular tachycardia
Doctor S. Bhatia (Rochester, US)
Abstract Slides
Presentation thumbnail
Targeting the hidden substrate unmasked by right ventricular extrastimulation improves ventricular tachycardia ablation outcome after myocardial infarction.
Miss C. Brouwer (Leiden, NL)
Abstract
Presentation thumbnail
Previous catheter ablation is the strongest predictor of conversion in recent-onset atrial fibrillation - Results from the prospective HAMBURG-AF study
Doctor B. Schulte Steinberg (Goeppingen, DE)
Abstract
Presentation thumbnail
Right versus left durable pulmonary vein isolation using the first and second generation cryoballoons: comparative results from a french multicenter study.
Professor R. Martins (Rennes, FR)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Catheter ablation

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources